[HTML][HTML] Renal cell carcinoma: a review of biology and pathophysiology

S Nabi, ER Kessler, B Bernard, TW Flaig… - F1000Research, 2018 - ncbi.nlm.nih.gov
Over the past decade, our understanding of the biology and pathophysiology of renal cell
carcinoma (RCC) has improved significantly. Insight into the disease process has helped us …

Current updates and future perspectives on the management of renal cell carcinoma

D Singh - Life sciences, 2021 - Elsevier
Renal cell carcinoma (RCC) refers to renal-epithelial cancer, which represents over 90% of
kidney cancer and is a cause for cancer related deaths in the world. Studies suggested …

[HTML][HTML] Kaempferol inhibits the invasion and migration of renal cancer cells through the downregulation of AKT and FAK pathways

TW Hung, PN Chen, HC Wu, SW Wu… - … Journal of Medical …, 2017 - ncbi.nlm.nih.gov
Kaempferol, which is isolated from several natural plants, is a polyphenol belonging to the
subgroup of flavonoids. Kaempferol exhibits various pharmacological activities, including …

Frequency, incidence and survival outcomes of clear cell renal cell carcinoma in the United States from 1973 to 2014: a SEER-based analysis

X Feng, L Zhang, W Tu, S Cang - Medicine, 2019 - journals.lww.com
Frequency, incidence and survival outcomes of clear cell ren... : Medicine Frequency,
incidence and survival outcomes of clear cell renal cell carcinoma in the United States from …

[HTML][HTML] Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?

A Rühle, N Andratschke, S Siva… - Clinical and translational …, 2019 - Elsevier
Renal cell carcinoma (RCC) has traditionally been regarded as radioresistant tumor based
on preclinical data and negative clinical trials using conventional fractionated radiotherapy …

The molecular characteristics of non-clear cell renal cell carcinoma: what's the story morning glory?

A Marchetti, M Rosellini, V Mollica, A Rizzo… - International Journal of …, 2021 - mdpi.com
Non-clear cell renal cell carcinomas are a miscellaneous group of tumors that include
different histological subtypes, each one characterized by peculiarity in terms of genetic …

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma

TE Hutson, RM Bukowski, BI Rini, ME Gore… - British journal of …, 2014 - nature.com
Background: We retrospectively analyzed sunitinib outcome as a function of age in
metastatic renal cell carcinoma (mRCC) patients. Methods: Data were pooled from 1059 …

Complications after radical and partial nephrectomy as a function of age

WT Lowrance, DS Yee, C Savage, AM Cronin… - The Journal of …, 2010 - Elsevier
PURPOSE: Partial nephrectomy may be underused compared with radical nephrectomy in
elderly patients due to concerns about higher complication rates. We determined if the …

Risk for renal cell carcinoma in chronic hepatitis C infection

SC Gordon, D Moonka, KA Brown, C Rogers… - … , biomarkers & prevention, 2010 - AACR
Background: Chronic infection with hepatitis C virus (HCV) confers increased risk for chronic
renal disease, and numerous reports suggest an association with renal cell carcinoma …

Severe Immune-Related Adverse Events in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma Are Associated with PDCD1 Polymorphism

M Kobayashi, K Numakura, S Hatakeyama, Y Muto… - Genes, 2022 - mdpi.com
Single nucleotide polymorphisms (SNPs) reportedly influence the effect of nivolumab in
metastatic renal cell carcinoma (mRCC). This study aimed to evaluate the relationship …